Paul Mandel

Yao Fehlis, Paul Mandel, Charles Crain et al.

Self-driving labs are transforming drug discovery by enabling automated, AI-guided experimentation, but they face challenges in orchestrating complex workflows, integrating diverse instruments and AI models, and managing data efficiently. Artificial addresses these issues with a comprehensive orchestration and scheduling system that unifies lab operations, automates workflows, and integrates AI-driven decision-making. By incorporating AI/ML models like NVIDIA BioNeMo - which facilitates molecular interaction prediction and biomolecular analysis - Artificial enhances drug discovery and accelerates data-driven research. Through real-time coordination of instruments, robots, and personnel, the platform streamlines experiments, enhances reproducibility, and advances drug discovery.

Yao Fehlis, Charles Crain, Aidan Jensen et al.

The pharmaceutical industry faces unprecedented challenges in drug discovery, with traditional approaches struggling to meet modern therapeutic development demands. This paper introduces a novel AI framework, Tippy, that transforms laboratory automation through specialized AI agents operating within the Design-Make-Test-Analyze (DMTA) cycle. Our multi-agent system employs five specialized agents - Supervisor, Molecule, Lab, Analysis, and Report, with Safety Guardrail oversight - each designed to excel in specific phases of the drug discovery pipeline. Tippy represents the first production-ready implementation of specialized AI agents for automating the DMTA cycle, providing a concrete example of how AI can transform laboratory workflows. By leveraging autonomous AI agents that reason, plan, and collaborate, we demonstrate how Tippy accelerates DMTA cycles while maintaining scientific rigor essential for pharmaceutical research. The system shows significant improvements in workflow efficiency, decision-making speed, and cross-disciplinary coordination, offering a new paradigm for AI-assisted drug discovery.

Yao Fehlis, Charles Crain, Aidan Jensen et al.

Building on the conceptual framework presented in our previous work on agentic AI for pharmaceutical research, this paper provides a comprehensive technical analysis of Tippy's multi-agent system implementation for drug discovery laboratory automation. We present a distributed microservices architecture featuring five specialized agents (Supervisor, Molecule, Lab, Analysis, and Report) that coordinate through OpenAI Agents SDK orchestration and access laboratory tools via the Model Context Protocol (MCP). The system architecture encompasses agent-specific tool integration, asynchronous communication patterns, and comprehensive configuration management through Git-based tracking. Our production deployment strategy utilizes Kubernetes container orchestration with Helm charts, Docker containerization, and CI/CD pipelines for automated testing and deployment. The implementation integrates vector databases for RAG functionality and employs an Envoy reverse proxy for secure external access. This work demonstrates how specialized AI agents can effectively coordinate complex laboratory workflows while maintaining security, scalability, reliability, and integration with existing laboratory infrastructure through standardized protocols.